The DOI matches its Crossref record; 31 of the 32 references it cites were found in a registry or an index.
Corticobasal degeneration and progressive supranuclear palsy share a common tau haplotype
Abstract
Objective To analyze the association of polymorphisms in the tau gene with pathologically confirmed corticobasal degeneration (CBD). Background The authors previously described an extended tau haplotype (H1) that covers the human tau gene and is associated with the development of progressive supranuclear palsy (PSP). The authors now extend this analysis to CBD, a neurodegenerative condition with clinical and neuropathologic similarities to PSP. Like PSP, CBD is associated with accumulation of aggregates containing the 4-repeat isoforms of tau. Because of difficulty in diagnosis of CBD, the authors only analyzed cases with pathologically confirmed CBD. Methods The authors collected 57 unrelated, neuropathologically confirmed cases of CBD. Tau sequencing in these cases failed to show the presence of pathogenic mutations. Polymorphisms that spanned the tau gene were analyzed in all CBD cases and controls. Results Analyzing tau polymorphisms in CBD cases showed that the frequency of H1 and H1/H1 was significantly increased when analyzing all cases and when separating by country of origin. H1 frequency in all CBD cases was 0.921, compared with a control frequency of 0.766 (X(2) = 9.1, p = 0.00255 [1df], OR 3.56 [8.43 > CI 95% > 1.53]). The H1/H1 frequency was also significantly higher at 0.842 compared with 0.596 in age-matched controls (X(2) = 17.42, p = 0.00016, 2df), OR 3.61 [7.05 > CI 95% > 1.85]). Conclusions The CBD tau association described here suggests that PSP and CBD sh…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“An association of CBD with the H1 haplotype was first reported in a series of 18 cases (16 corticobasal syndrome patients and two autopsy-confirmed CBD cases)15 and subsequently confirmed in a larger autopsy series of 57 cases16.”
From Genome-wide association study of corticobasal degeneration identifies risk variants shared with progressive supranuclear palsy (2015) · cites this paper as [16]
Citations
Cites
Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17
Hutton, M., Lendon, C. L., Rizzu, P., Baker, M., Froelich, S., Houlden, H., Pickering-Brown, S., Chakraverty, S., Isaacs, A., Grover, A., et al. (1998) · Nature · doi:10.1038/31508 · Cited by 3,498
Self-citationLitvan, I., Agid, Y., Calne, D., Campbell, G., Dubois, B., Duvoisin, R. C., Goetz, C. G., Golbe, L. I., Grafman, J., Growdon, J. H., et al. (1996) · Neurology · doi:10.1212/wnl.47.1.1 · Cited by 2,538
Self-citationGoedert, M., Spillantini, M. G., Jakes, R., Rutherford, D., & Crowther, R. A. (1989) · Neuron · doi:10.1016/0896-6273(89)90210-9 · Cited by 2,492
Mutation in the tau gene in familial multiple system tauopathy with presenile dementia
Spillantini, M. G., Murrell, J. R., Goedert, M., Farlow, M. R., Klug, A., & Ghetti, B. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.13.7737 · Cited by 1,474
Tau is a candidate gene for chromosome 17 frontotemporal dementia
Poorkaj, P., Bird, T. D., Wijsman, E., Nemens, E., Garruto, R. M., Anderson, L., Andreadis, A., Wiederholt, W. C., Raskind, M., & Schellenberg, G. D. (1998) · Annals of Neurology · doi:10.1002/ana.410430617 · Cited by 1,374
Mutation-specific functional impairments in distinct tau isoforms of hereditary FTDP-17.
Hong, M., Zhukareva, V., Vogelsberg-Ragaglia, V., Wszolek, Z., Reed, L., Miller, B., Geschwind, D., Bird, T., McKeel, D., Goate, A., et al. (1998) · Science · doi:10.1126/science.282.5395.1914 · Cited by 1,024
Association of an Extended Haplotype in the Tau Gene with Progressive Supranuclear Palsy
Baker, M., Litvan, I., Houlden, H., Adamson, J., Dickson, D., Perez-Tur, J., Hardy, J., Lynch, T., Bigio, E., & Hutton, M. (1999) · Human Molecular Genetics · doi:10.1093/hmg/8.4.711 · Cited by 781
Self-citationTau protein pathology in neurodegenerative diseases
Spillantini, M. G., & Goedert, M. (1998) · Trends in Neurosciences · doi:10.1016/s0166-2236(98)01337-x · Cited by 683
Structure and novel exons of the human .tau. gene
Andreadis, A., Brown, W. M., & Kosik, K. S. (1992) · Biochemistry · doi:10.1021/bi00158a027 · Cited by 659
Corticodentatonigral Degeneration With Neuronal Achromasia
Rebeiz, J. J., Kolodny, E. H., & Richardson, E. P. (1968) · Archives of Neurology · doi:10.1001/archneur.1968.00470310034003 · Cited by 627
Cited by
Sorted by citations
Items 401–409 of 409
Tauber, C. V., Schwarz, S. C., Rösler, T. W., Arzberger, T., Gentleman, S., Windl, O., Krumbiegel, M., Reis, A., Ruf, V., Herms, J. W., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26574610
Koga, S., Metrick, M. A., Golbe, L. I., Santambrogio, A., Kim, M., Soto‐Beasley, A. I., Walton, R. L., Baker, M., De Castro, C. F., Deture, M. A., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26593406
Self-citationScotton, W. J., Valentino, R. R., Martínez-Carrasco, A., Real, R., Macpherson, H. L., Tamvaka, N., Mok, K. Y., Heckman, M. G., Kobylecki, C., Escott‐Price, V., et al. (2025) · medRxiv · doi:10.64898/2025.12.21.25342758
Self-citationEvaluating MAPT p.A152T as a risk factor for the 3R tauopathy Pick’s disease
Tamvaka, N., Scotton, W. J., Lilley, M. T., Shoai, M., Gavrielatos, M., Heckman, M. G., Soto‐Beasley, A. I., Roemer, S. F., Baker, M., Rademakers, R., et al. (2026) · Brain Communications · doi:10.1093/braincomms/fcag266
Self-citationArtificial Synthetic Protein Mimetics As Pathology-Targeted Therapeutics
Dohoney, R. A. (2026) · Digital Commons - DU (University of Denver) · doi:10.56902/etdcrp.2026.62
Genetic correlates of corticobasal degeneration: a systematic review and meta-analysis
Thompson, J., & Johnson, P. K. (2026) · Journal of Neurology · doi:10.1007/s00415-026-14218-w
Genetics of Atypical Parkinsonism
Stamelou, M., & Bhatia, K. P. (2015) · Springer eBooks · doi:10.1007/978-3-319-17223-1_3
Self-citationde Vries, J. J., & Leenders, K. L. (2009) · Bohn Stafleu van Loghum eBooks · doi:10.1007/978-90-313-8061-9_26
Genetic studies of LRRK2 and PINK1 in Parkinson's disease
Toft, M. (2007) · BIBSYS Brage (BIBSYS (Norway))
Metadata
- Authors
- Houlden, H., Baker, M., Morris, H. R., MacDonald, N., Pickering–Brown, S., Adamson, J., Lees, A. J., Rossor, M. N., Quinn, N. P., Kertesz, A., Khan, M. N., Hardy, J., Lantos, P. L., St. George–Hyslop, P., Munoz, D. G., Mann, D., Lang, A. E., Bergeron, C., Bigio, E. H., Litvan, I., Bhatia, K. P., Dickson, D., Wood, N. W., & Hutton, M.
- Affiliations
- St Bartholomew's Hospital (GB)
- From Neurogenetics (Drs. Houlden, Morris, Lees, Rossor, Quinn, Khan, Lantos, and Bhatia), Clinical Neurology and Dementia Research Group, Institute of Neurology, London; Mayo Clinic Jacksonville (Dr. Dickson and M. Baker and J. Adamson), Jacksonville, FL; Department of Gynaecological Oncology (Dr. MacDonald), St. Bartholomew’s Hospital, London; School of Biological Sciences (Dr. Pickering–Brown) and Department of Medicine (Dr. Mann), University of Manchester; Department of Neuropathology (M.N. Khan...
- National Institutes of Health (US)
- ORCID
- Venue
- Neurology
- Published
- 2001-06-26
- Volume
- 56
- Issue
- 12
- Pages
- 1702-1706
- ISSN
- 0028-3878 (ISSN-L)
- 1526-632X
- OpenAlex
- W2045671840
- Cited by
- 409
- References
- 32
- Citations by year
- 2026: 3 · 2025: 11 · 2024: 14 · 2023: 9 · 2022: 2 · 2021: 11 · 2020: 11 · 2019: 11 · 2018: 10 · 2017: 14 · 2016: 19 · 2015: 16 · 2014: 16 · 2013: 7 · 2012: 16
- FWCI
- 16.77
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Neurology (publishedVersion)
- PubMed (publishedVersion)
- UCL Discovery (University College London) (submittedVersion)
- ORCA Online Research @Cardiff (Cardiff University) (submittedVersion)
- Research Explorer (The University of Manchester) (submittedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- corticobasal degeneration, progressive supranuclear palsy, tau gene, tau aggregation, genetic association, neurodegeneration
- MeSH terms
- Genotype, Haplotypes, Humans, Supranuclear Palsy, Progressive, Polymerase Chain Reaction, tau Proteins, Neurodegenerative Diseases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
